Norinchukin Bank’s Amgen AMGN Stock Holding History

Norinchukin Bank’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.4M	Buy	60,886 +649	+1%	+$231K	0.25%	64
2025 Q4	$19.7M	Buy	60,237 +5,106	+9%	+$1.62M	0.23%	67
2025 Q3	$15.6M	Sell	55,131 -1,419	-3%	-$412K	0.21%	69
2025 Q2	$15.8M	Buy	56,550 +4,230	+8%	+$1.2M	0.24%	70
2025 Q1	$16.3M	Buy	52,320 +13,156	+34%	+$3.88M	0.3%	56
2024 Q4	$10.2M	Buy	39,164 +1,706	+5%	+$506K	0.22%	74
2024 Q3	$12.1M	Buy	37,458 +4,203	+13%	+$1.37M	0.29%	59
2024 Q2	$10.4M	Sell	33,255 -400	-1%	-$118K	0.3%	55
2024 Q1	$9.57M	Sell	33,655 -3,247	-9%	-$950K	0.29%	59
2023 Q4	$10.6M	Sell	36,902 -5,190	-12%	-$1.41M	0.25%	54
2023 Q3	$11.3M	Sell	42,092 -27,715	-40%	-$6.92M	0.27%	54
2023 Q2	$15.5M	Buy	69,807 +10,077	+17%	+$2.34M	0.26%	66
2023 Q1	$14.4M	Buy	59,730 +933	+2%	+$229K	0.28%	59
2022 Q4	$15.4M	Sell	58,797 -10,801	-16%	-$2.9M	0.33%	55
2022 Q3	$15.7M	Buy	69,598 +3,726	+6%	+$903K	0.32%	56
2022 Q2	$16M	Sell	65,872 -16,999	-21%	-$4.17M	0.31%	55
2022 Q1	$20M	Buy	82,871 +3,862	+5%	+$887K	0.27%	69
2021 Q4	$17.8M	Sell	79,009 -6,295	-7%	-$1.33M	0.22%	77
2021 Q3	$18.1M	Buy	85,304 +4,045	+5%	+$931K	0.25%	71
2021 Q2	$19.8M	Buy	81,259 +5,822	+8%	+$1.43M	0.29%	57
2021 Q1	$18.8M	Sell	75,437 -744	-1%	-$178K	0.26%	56
2020 Q4	$17.5M	Buy	76,181 +285	+0.4%	+$65.7K	0.25%	61
2020 Q3	$19.3M	Buy	75,896 +24,477	+48%	+$6.06M	0.31%	50
2020 Q2	$12.1M	Sell	51,419 -924	-2%	-$211K	0.21%	68
2020 Q1	$10.6M	Sell	52,343 -46,013	-47%	-$10.1M	0.21%	67
2019 Q4	$23.7M	Sell	98,356 -8,018	-8%	-$1.77M	0.31%	60
2019 Q3	$20.6M	Buy	106,374 +453	+0.4%	+$87K	0.29%	53
2019 Q2	$19.5M	Sell	105,921 -46,002	-30%	-$8.24M	0.3%	53
2019 Q1	$28.9M	Buy	151,923 +667	+0.4%	+$127K	0.37%	51
2018 Q4	$29.4M	Buy	151,256 +34,865	+30%	+$6.8M	0.41%	45
2018 Q3	$24.1M	Buy	116,391 +6,696	+6%	+$1.32M	0.33%	50
2018 Q2	$20.2M	Buy	109,695 +8,348	+8%	+$1.48M	0.3%	54
2018 Q1	$17.3M	Buy	101,347 +6,225	+7%	+$1.14M	0.29%	58
2017 Q4	$16.5M	Buy	95,122 +3,535	+4%	+$626K	0.29%	55
2017 Q3	$17.1M	Buy	91,587 +2,661	+3%	+$471K	0.33%	48
2017 Q2	$15.3M	Buy	88,926 +3,349	+4%	+$545K	0.31%	51
2017 Q1	$14M	Buy	85,577 +2,684	+3%	+$446K	0.3%	49
2016 Q4	$12.1M	Buy	82,893 +5,054	+6%	+$761K	0.28%	56
2016 Q3	$13M	Buy	77,839 +410	+0.5%	+$69.3K	0.31%	47
2016 Q2	$11.8M	Buy	77,429 +932	+1%	+$145K	0.29%	58
2016 Q1	$11.5M	Buy	76,497 +3,157	+4%	+$469K	0.28%	58
2015 Q4	$11.9M	Sell	73,340 -8,108	-10%	-$1.27M	0.3%	53
2015 Q3	$11.3M	Buy	81,448 +267	+0.3%	+$42.1K	0.29%	51
2015 Q2	$12.5M	Sell	81,181 -1,717	-2%	-$275K	0.32%	46
2015 Q1	$13.3M	Sell	82,898 -887	-1%	-$140K	0.32%	45
2014 Q4	$13.3M	Buy	83,785 +14,608	+21%	+$2.28M	0.33%	42
2014 Q3	$9.72M	Sell	69,177 -6,427	-9%	-$839K	0.28%	48
2014 Q2	$8.95M	Sell	75,604 -7,867	-9%	-$911K	0.26%	47
2014 Q1	$10.3M	Buy	83,471 +5,643	+7%	+$684K	0.29%	48
2013 Q4	$8.88M	Buy	77,828 +5,773	+8%	+$657K	0.24%	48
2013 Q3	$8.06M	Buy	72,055 +2,684	+4%	+$291K	0.23%	50
2013 Q2	$6.84M	Buy	+69,371	New	+$7.2M	0.21%	51

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norinchukin Bank's AMGN Position: Q1 2026 in Review

Norinchukin Bank increased its Amgen (AMGN) stake by 1.1% in Q1 2026, buying an estimated $231K and bringing the position to 60,886 shares worth $21.4M. The position accounts for 0.25% of the portfolio, ranked #64.

Norinchukin Bank first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.4M in Q4 2018. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Norinchukin Bank held 60,886 shares of Amgen worth $21.4M as of Q1 2026.
Norinchukin Bank bought 649 Amgen shares in Q1 2026, an estimated $231K.
Amgen made up 0.25% of Norinchukin Bank's portfolio in Q1 2026, its #64 holding.
Norinchukin Bank first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
Norinchukin Bank's Amgen position peaked at $29.4M in Q4 2018.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.